UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer

Modern pathology, 2020-09, Vol.33 (9), p.1746-1752

2020

Volltextzugriff (PDF)

Antibody validation for protein expression on tissue slides: a protocol for immunohistochemistry

BioTechniques, 2020-12, Vol.69 (6), p.460-468

2020

Volltextzugriff (PDF)

Quantitative assessment of the immune microenvironment in African American Triple Negative Breast Cancer: a case-control study

Breast cancer research : BCR, 2021-12, Vol.23 (1), p.113-113, Article 113

2021

Volltextzugriff (PDF)

Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer

Laboratory investigation, 2022-10, Vol.102 (10), p.1101-1108

2022

Volltextzugriff (PDF)

Spatially Informed Gene Signatures for Response to Immunotherapy in Melanoma

Clinical cancer research, 2024-08, Vol.30 (16), p.3520-3532

2024

Volltextzugriff (PDF)

Targeting the CSF1/CSF1R axis is a potential treatment strategy for malignant meningiomas

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (11), p.1922-1935

2021

Volltextzugriff (PDF)

Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer

Laboratory investigation, 2022-10, Vol.102 (10), p.1143-1149

2022

Volltextzugriff (PDF)

Quantitative assessment of immune cell populations and associations with clinical outcomes in African-American (AA) versus Caucasian triple-negative breast cancer (TNBC)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e14180-e14180

2019

Volltextzugriff (PDF)

Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer

Clinical cancer research, 2022-06, Vol.28 (12), p.2587-2597

2022

Volltextzugriff (PDF)

Discovery of Biomarkers of Resistance to Immune Checkpoint Blockade in NSCLC Using High-Plex Digital Spatial Profiling

Journal of thoracic oncology, 2022-08, Vol.17 (8), p.991-1001

2022

Volltextzugriff (PDF)

Advances in quantitative immunohistochemistry and their contribution to breast cancer

Expert review of molecular diagnostics, 2020-05, Vol.20 (5), p.509-522

2020

Volltextzugriff (PDF)

Alpha-smooth Muscle Actin Expression in the Stroma Predicts Resistance to Trastuzumab in Patients with Early-stage HER2-positive Breast Cancer

Clinical cancer research, 2021-11, Vol.27 (22), p.6156-6163

2021

Volltextzugriff (PDF)

Spatially Resolved and Quantitative Analysis of the Immunological Landscape in Human Meningiomas

Journal of neuropathology and experimental neurology, 2021-02, Vol.80 (2), p.150-159

2021

Volltextzugriff (PDF)

Development of an immunohistochemical assay for Siglec-15

Laboratory investigation, 2022-07, Vol.102 (7), p.771-778

2022

Volltextzugriff (PDF)

Quantitative Assessment of Siglec-15 Expression in Lung, Breast, HNSCC and Bladder Cancer

Laboratory investigation, 2022-05, Vol.102 (10), p.1143-1149

2022

Volltextzugriff (PDF)

Programmed Death-Ligand 1 and Programmed Death-Ligand 2 mRNAs Measured Using Closed-System Quantitative Real-Time Polymerase Chain Reaction Are Associated With Outcome and High Negative Predictive Value in Immunotherapy-Treated NSCLC

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.1078-1085

2022

Volltextzugriff (PDF)

Discovery of biomarkers of resistance to immune checkpoint blockade in non-small-cell lung cancer (NSCLC) using high-plex digital spatial profiling

Journal of thoracic oncology, 2022-04, Vol.17 (8), p.991-1001

2022

Volltextzugriff (PDF)

Immunological Differences Between Immune-Rich Estrogen Receptor–Positive and Immune-Rich Triple-Negative Breast Cancers

JCO precision oncology, 2020-06 (4), p.767-779

2020

Volltextzugriff (PDF)

Suppression of dsRNA response genes and innate immunity following Oct4, Stella, and Nanos2 overexpression in mouse embryonic fibroblasts

Cytokine (Philadelphia, Pa.), 2018-06, Vol.106, p.1-11

2018

Volltextzugriff (PDF)

Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer

Laboratory investigation, 2022-10, Vol.102 (10), p.1143

2022

Volltextzugriff (PDF)

Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer

Laboratory investigation, 2022-10, Vol.102 (10), p.1101

2022

Volltextzugriff (PDF)

Quantitative, Spatially Defined Expression of Leukocyte-associated Immunoglobulin-like Receptor in Non-small Cell Lung Cancer

Cancer research communications, 2023-03, Vol.3 (3), p.471-482

2023

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Zeitschrift / SerieCancer Research

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Humans
(14)
Oncology
(10)
Female
(6)
Pathology
(6)
Breast Cancer
(5)
Immunohistochemistry
(5)
Immunotherapy
(5)
Antibodies
(4)
B7-H1 Antigen - Metabolism
(4)
Carcinoma, Non-Small-Cell Lung - Pathology
(4)
Immunofluorescence
(4)
Laboratory Medicine
(4)
Lung Cancer
(4)
Medicine
(4)
Medicine & Public Health
(4)
Medicine/public Health
(4)
Pd-L1 Protein
(4)
Tumor Microenvironment
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer

Antibody validation for protein expression on tissue slides: a protocol for immunohistochemistry

Quantitative assessment of the immune microenvironment in African American Triple Negative Breast Cancer: a case-control study

Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer

Spatially Informed Gene Signatures for Response to Immunotherapy in Melanoma

Targeting the CSF1/CSF1R axis is a potential treatment strategy for malignant meningiomas

Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer

Quantitative assessment of immune cell populations and associations with clinical outcomes in African-American (AA) versus Caucasian triple-negative breast cancer (TNBC)

Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer

Discovery of Biomarkers of Resistance to Immune Checkpoint Blockade in NSCLC Using High-Plex Digital Spatial Profiling

Advances in quantitative immunohistochemistry and their contribution to breast cancer

Alpha-smooth Muscle Actin Expression in the Stroma Predicts Resistance to Trastuzumab in Patients with Early-stage HER2-positive Breast Cancer

Spatially Resolved and Quantitative Analysis of the Immunological Landscape in Human Meningiomas

Development of an immunohistochemical assay for Siglec-15

Quantitative Assessment of Siglec-15 Expression in Lung, Breast, HNSCC and Bladder Cancer

Programmed Death-Ligand 1 and Programmed Death-Ligand 2 mRNAs Measured Using Closed-System Quantitative Real-Time Polymerase Chain Reaction Are Associated With Outcome and High Negative Predictive Value in Immunotherapy-Treated NSCLC

Discovery of biomarkers of resistance to immune checkpoint blockade in non-small-cell lung cancer (NSCLC) using high-plex digital spatial profiling

Immunological Differences Between Immune-Rich Estrogen Receptor–Positive and Immune-Rich Triple-Negative Breast Cancers

Suppression of dsRNA response genes and innate immunity following Oct4, Stella, and Nanos2 overexpression in mouse embryonic fibroblasts

Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer

Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer

Quantitative, Spatially Defined Expression of Leukocyte-associated Immunoglobulin-like Receptor in Non-small Cell Lung Cancer

Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Aktive Filter

Suchergebnisse filtern